Clinical Trial Update: A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness.

View source ↗

Summary

A clinical trial update describes a study using CT radiomics to distinguish benign from malignant renal tumors and assess their aggressiveness. The study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Renal Cell Carcinoma (RCC) | Status: ACTIVE_NOT_RECRUITING